TrialCancer chemotherapy and pharmacology2020

A randomized, double-blind, single-dose study to evaluate the biosimilarity of QL1101 with bevacizumab in healthy male subjects.

Ya-Nan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.